Effects of block-replace regimen in patients with autoimmune hypothyroidism converted to Graves' disease.

IF 2.4 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Ana-Maria Stancu, Daniela Alexandrescu, Corin Badiu
{"title":"Effects of block-replace regimen in patients with autoimmune hypothyroidism converted to Graves' disease.","authors":"Ana-Maria Stancu, Daniela Alexandrescu, Corin Badiu","doi":"10.1007/s42000-023-00496-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>We present two cases of autoimmune hypothyroidism converted to Graves' disease (GD) and their medical management.</p><p><strong>Methods: </strong>We tested thyroid function and thyroid antibodies and performed an ophthalmologic examination and neck ultrasound in two patients with autoimmune hypothyroidism converted to GD during a follow-up of several years.</p><p><strong>Case reports: </strong>The first case is a 33 year-old woman with hypothyroidism due to Hashimoto's thyroiditis (HT). She developed signs and symptoms of hyperthyroidism after 7 years of treatment with the same dose of levothyroxine (LT<sub>4</sub>). Even when LT<sub>4</sub> therapy was discontinued, she remained thyrotoxic, with mild Graves' ophthalmopathy (GO) and very high thyroid-stimulating hormone receptor antibodies (TRAb > 40 IU/L, reference range: <1.75 IU/L). Antithyroid medication was started on a titration regimen, without achievement of euthyroidism. She was switched to a block and replace regimen, using 20 mg of methimazole (MMI) and 75 mcg of LT<sub>4</sub> daily, with normalization of thyroid hormones and improvement of GO without steroids. The second case is a 57 year-old man with a 2-year positive medical history of HT and 6 months of LT<sub>4</sub> treatment. He developed hyperthyroidism and moderate-severe GO. Despite stopping LT<sub>4</sub> and initiating antithyroid medication in a titration regimen, he did not achieve euthyroidism and had active GO. Pulse glucocorticoid therapy and switching to a block-replace regimen was required to achieve euthyroidism and reduce ocular proptosis and diplopia.</p><p><strong>Conclusion: </strong>Spontaneous autoimmune conversion of hypothyroidism to hyperthyroidism can occur at any time: it is important to promptly identify these cases so as to manage them effectively.</p>","PeriodicalId":50399,"journal":{"name":"Hormones-International Journal of Endocrinology and Metabolism","volume":" ","pages":"107-111"},"PeriodicalIF":2.4000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hormones-International Journal of Endocrinology and Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s42000-023-00496-w","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/13 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: We present two cases of autoimmune hypothyroidism converted to Graves' disease (GD) and their medical management.

Methods: We tested thyroid function and thyroid antibodies and performed an ophthalmologic examination and neck ultrasound in two patients with autoimmune hypothyroidism converted to GD during a follow-up of several years.

Case reports: The first case is a 33 year-old woman with hypothyroidism due to Hashimoto's thyroiditis (HT). She developed signs and symptoms of hyperthyroidism after 7 years of treatment with the same dose of levothyroxine (LT4). Even when LT4 therapy was discontinued, she remained thyrotoxic, with mild Graves' ophthalmopathy (GO) and very high thyroid-stimulating hormone receptor antibodies (TRAb > 40 IU/L, reference range: <1.75 IU/L). Antithyroid medication was started on a titration regimen, without achievement of euthyroidism. She was switched to a block and replace regimen, using 20 mg of methimazole (MMI) and 75 mcg of LT4 daily, with normalization of thyroid hormones and improvement of GO without steroids. The second case is a 57 year-old man with a 2-year positive medical history of HT and 6 months of LT4 treatment. He developed hyperthyroidism and moderate-severe GO. Despite stopping LT4 and initiating antithyroid medication in a titration regimen, he did not achieve euthyroidism and had active GO. Pulse glucocorticoid therapy and switching to a block-replace regimen was required to achieve euthyroidism and reduce ocular proptosis and diplopia.

Conclusion: Spontaneous autoimmune conversion of hypothyroidism to hyperthyroidism can occur at any time: it is important to promptly identify these cases so as to manage them effectively.

Abstract Image

阻断替代方案对自身免疫性甲状腺功能减退症转为Graves病患者的影响。
目的:我们报告两例自身免疫性甲状腺功能减退症转化为Graves病(GD)的病例及其医疗处理。方法:在几年的随访中,我们对两名自身免疫性甲状腺功能减退症转为GD的患者进行了甲状腺功能和甲状腺抗体测试,并进行了眼科检查和颈部超声检查。病例报告:第一例是一名33岁的女性,因桥本甲状腺炎(HT)而患有甲状腺功能减退症。在用相同剂量的左甲状腺素(LT4)治疗7年后,她出现了甲状腺功能亢进的体征和症状。即使停止LT4治疗,她仍然具有甲状腺毒性,患有轻度Graves眼病(GO)和非常高的促甲状腺激素受体抗体(TRAb>40 IU/L,参考范围:每天4次,甲状腺激素正常化,GO改善,不使用类固醇。第二例为57岁男性,有2年HT阳性病史,接受LT4治疗6个月。他出现甲状腺功能亢进和中重度GO。尽管停止了LT4并开始用滴定方案进行抗甲状腺药物治疗,但他没有实现甲状腺功能正常ism,GO活跃。需要脉冲糖皮质激素治疗并改用阻断替代方案来实现甲状腺功能亢进并减少眼球突出和复视。结论:甲状腺功能减退症向甲状腺功能亢进症的自发自身免疫性转化随时可能发生:及时发现这些病例以有效治疗是很重要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.90
自引率
0.00%
发文量
76
审稿时长
6-12 weeks
期刊介绍: Hormones-International Journal of Endocrinology and Metabolism is an international journal published quarterly with an international editorial board aiming at providing a forum covering all fields of endocrinology and metabolic disorders such as disruption of glucose homeostasis (diabetes mellitus), impaired homeostasis of plasma lipids (dyslipidemia), the disorder of bone metabolism (osteoporosis), disturbances of endocrine function and reproductive capacity of women and men. Hormones-International Journal of Endocrinology and Metabolism particularly encourages clinical, translational and basic science submissions in the areas of endocrine cancers, nutrition, obesity and metabolic disorders, quality of life of endocrine diseases, epidemiology of endocrine and metabolic disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信